AntiHypertensives Flashcards
1
Q
MOA of Thiazide Diuretics
A
- increase the excretion of Na+ and water by blocking Na+ reabsorption
- decreases blood volume and arterial resistance
- # 1 drug choice in most cases
- for HTN or edema
2
Q
Hydrochlorothiazide
A
- aka HCTZ, thiazide diuretic
- blocks Na+ reabsorption in early segment of distal convoluted tubule
- PO only
3
Q
Chlorthalidone
A
- thiazide diuretic
- 1.5-2 times more potent as HCTZ
- PO only
4
Q
Adverse effects of thiazide diuretics
A
- hyponatremia/dehydration
- hypokalemia
- hyperuricemia
- hyperglycemia
- hyperlipidemia
- photosensitivity
- contraindicated if sulfa-allergy or CKD
5
Q
MOA of Loop Diuretics
A
- inhibit co-transport of Na+/K+/2Cl- –> increases Na+ and K+ excretion
- more diuresis than thiazides, shorter duration
- for HTN or edema
6
Q
Furosemide
A
- Loop Diuretic
- most freq. prescribed of this class
- prevents passive reabsorption of water –> profound diuresis
- PO or IV
7
Q
Bumetanide
A
- Loop diuretic
- more potent than Furosemide
- PO or IV
8
Q
Adverse Effects of Loop Diuretics
A
- Orthostatic hypotension
- electrolyte imbalance (hyponatremia, dehydration)
- hypokalemia
- hyperuricemia
- hyperglycemia
- hyperlipidemia
- photosensitivity
- ototoxicity ( esp. in IV route)
- contraindicated if sulfa-allergy
9
Q
MoA of Potassium sparing diuretics
A
- less potent than thiazides and loop diuretics
- provide modest increase in urine production with less potassium excretion
- meds often coupled with HCTZ
- for HTN or edema
10
Q
Amiloride
A
- Potassium Sparing diuretic
- MoA: directly blocks Na+/K+ pump; prevents Na+ reabsorption and K+ secretion in collecting tubule
- PO only
11
Q
Triamtrene
A
- Potassium Sparing diuretic
- directly blocks Na+/K+ pump
- mild diuresis; excretes Na+, prevents secretion of K+
- PO only
12
Q
Spironolactone or Eplerenone
A
- Potassium sparing Diuretics
- aldosterone antagonist to work in collecting duct –> Na+ excretion, K+ reabsorption
- PO only
13
Q
Adverse Effects of potassium sparing diuretics
A
- hyperkalemia (esp if in combo with ACE, ARB, or K+ supplement)
- contraindicated in patients with CKD or hyperkalemia
14
Q
Adverse effects specific to spironolactone
A
- gynecomastia in males
- abnormal vaginal bleeding
- BBW: tumorigenic
15
Q
MoA of ACE Inhibitors
A
- inhibit angiotensin I converting enzyme –> block formation of angiotensin II –> decreased angiotensin II levels
- inhibit bradykinin degradation –> increased bradykinin levels in lung (cough)
16
Q
Enalapril or Lisinopril
A
- ACE inhibitors
- Enalapril –> PO or IV
- Lisinopril –> PO
17
Q
Adverse Effects of ACE inhibitors
A
- BBW: injury/death to developing fetus
- first dose hypotension (abrupt drop of angiotensin II
- dry cough (bronchial/laryngeal irritation)
- Hyperkalemia
- Angioedema (increased permeability of capillaries, esp if IV)
18
Q
Indications of ACE inhibitors
A
- HTN
- MI
- prevention of MI, stroke, and death in patients at high risk of CVD
- CHF
19
Q
MoA of ARBs
A
- bind to angiotensin II receptor subtype –> block action of angiotensin II
- relaxes smooth muscle and promotes vasodilation
- decreases aldosterone release and increases renal Na+/water excretion
- alternate to ACEs
20
Q
Losartan or Valsartan
A
- ARBs
- both PO only
- Losartan 1st choice for this class
- higher cost, reserved for patients who develop cough with ACE inhibitors
21
Q
Indications of ARBs
A
- HTN
- MI
- CHF
- Prevention of stroke in patients with high risk of CVD
22
Q
Adverse effects of ARBs
A
- BBW: can cause injury/death to developing fetus
- no problems with cough
- hyperkalemia
- hypotension
- angioedema (rare)
- acute renal insufficiency
- additive hypotensive effects when in combo with other antihypertensives
23
Q
ACE inhibior/ARB warning
A
- start with smallest dose possible due to hypotension risk
- may cause hyperkalemia in CKD patients or patients on other K+ sparing meds
- absolutely contraindicated in pregnancy
24
Q
MoA of Renin inhibitor
A
- Inhibits angiotensinogen to angiotensin I conversion
- does not block bradykinin breakdown (less cough than ACE-Is)
25
Q
Aliskiren
A
- Renin inhibitor; inhibits angiotensinogen to angiotensin I conversion
- can be used alone or in combo with other antihypertensives
- PO
26
Q
adverse effects of Renin inhibitors
A
- orthostatic hypotension
- hyperkalemia
- angioedema
- BBW: injury/death to developing fetus
27
Q
MoA of all types of CCBs
A
- inhibit influx of calcium via the voltage-dependent calcium channels in vascular smooth muscle
- relaxation of peripheral vasculature –> peripheral vasodilation
- each agent produces different degrees of systemic/coronary arterial vasodilation
28
Q
Dihydropyridines
A
- CCBs that act primarily on artieroles
- end in (-dipine)
- ex. Nifedipine, Amlodipine, Clevidipine